About IRadimed Corporation
https://www.iradimed.comIRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system.
CEO
Roger E. Susi
Compensation Summary
(Year 2024)
ETFs Holding This Stock
VTS.AX
Weight:0.00%
Shares:259.57K
IWM
Weight:0.03%
Shares:199.88K
XSU.TO
Weight:0.03%
Shares:199.88K
Summary
Showing Top 3 of 106
Ratings Snapshot
Rating : B+
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
BLACKROCK, INC.
Shares:1.02M
Value:$103.14M
BLACKROCK INC.
Shares:818.34K
Value:$83.09M
NINE TEN CAPITAL MANAGEMENT LLC
Shares:771.38K
Value:$78.32M
Summary
Showing Top 3 of 208
About IRadimed Corporation
https://www.iradimed.comIRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $21.2M ▲ | $9.66M ▲ | $5.58M ▼ | 26.3% ▼ | $0.44 ▼ | $7.68M ▼ |
| Q2-2025 | $20.41M ▲ | $9.17M ▼ | $5.77M ▲ | 28.29% ▲ | $0.45 ▲ | $7.92M ▲ |
| Q1-2025 | $19.51M ▲ | $9.41M ▲ | $4.69M ▼ | 24.02% ▼ | $0.37 ▼ | $5.63M ▼ |
| Q4-2024 | $19.39M ▲ | $8.96M ▲ | $5.15M ▲ | 26.54% ▼ | $0.41 ▲ | $6.54M ▲ |
| Q3-2024 | $18.33M | $8.4M | $5.05M | 27.55% | $0.4 | $5.99M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $56.53M ▲ | $114.72M ▲ | $16.37M ▲ | $98.35M ▲ |
| Q2-2025 | $53M ▲ | $106.45M ▲ | $12.15M ▲ | $94.3M ▲ |
| Q1-2025 | $50.33M ▼ | $101.73M ▲ | $11.68M ▲ | $90.05M ▲ |
| Q4-2024 | $52.23M ▲ | $98.33M ▲ | $11.51M ▲ | $86.82M ▲ |
| Q3-2024 | $51.72M | $94.25M | $10.81M | $83.43M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $5.58M ▼ | $6.99M ▼ | $-1.26M ▲ | $-2.19M ▲ | $3.53M ▲ | $5.85M ▲ |
| Q2-2025 | $5.77M ▲ | $7.75M ▲ | $-2.82M ▲ | $-2.26M ▲ | $2.66M ▲ | $4.92M ▲ |
| Q1-2025 | $4.69M ▼ | $4.29M ▼ | $-3.92M ▼ | $-2.28M ▲ | $-1.9M ▼ | $594.62K ▼ |
| Q4-2024 | $5.15M ▲ | $5.99M ▼ | $-3.06M ▲ | $-2.42M ▼ | $512.86K ▼ | $2.93M ▼ |
| Q3-2024 | $5.05M | $9.12M | $-4.01M | $-1.92M | $3.19M | $5.1M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 MRI Compatible Patient Vital Signs Monitoring Systems | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ |
Revenue by Geography
| Region | Q4-2024 | Q3-2025 | Q2-2025 | Q1-2025 |
|---|---|---|---|---|
 International | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 UNITED STATES | $20.00M ▲ | $20.00M ▲ | $20.00M ▲ | $20.00M ▲ |
CEO
Roger E. Susi
Compensation Summary
(Year 2024)
ETFs Holding This Stock
VTS.AX
Weight:0.00%
Shares:259.57K
IWM
Weight:0.03%
Shares:199.88K
XSU.TO
Weight:0.03%
Shares:199.88K
Summary
Showing Top 3 of 106
Ratings Snapshot
Rating : B+
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
BLACKROCK, INC.
Shares:1.02M
Value:$103.14M
BLACKROCK INC.
Shares:818.34K
Value:$83.09M
NINE TEN CAPITAL MANAGEMENT LLC
Shares:771.38K
Value:$78.32M
Summary
Showing Top 3 of 208